Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-17 Conversion | 2024-09-17 6:16 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Members of 10% Group 10% Owner | 16,809,237 | $0 | 897,587 (Indirect) | View |
Ownership | 2024-09-12 9:07 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 1,725,174 (Indirect) | View |
| 2024-07-15 Exercise | 2024-07-17 6:09 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 5,894,766 | $0 | 9,033,963 (Indirect) | View |
| 2024-07-11 Option Award | 2024-07-15 7:19 pm | N/A 2034-07-11 | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) *Director by Deputization Director | 264,000 | $0 | 264,000 (Indirect) | View |
| 2024-07-09 Option Award | 2024-07-11 6:47 pm | N/A 2027-01-28 | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director 10% Owner | 41,794,350 | $0 | 41,794,350 (Indirect) | View |
| 2024-06-12 Option Award | 2024-06-14 5:05 pm | N/A 2034-06-12 | Nuvalent Inc. | NUVL | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 10,077 | $0 | 20,001,101 (Indirect) | View |
| 2024-05-29 Option Award | 2024-06-03 6:31 pm | N/A 2034-05-29 | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner | 19,000 | $0 | 19,000 (Indirect) | View |
| 2024-03-15 Option Award | 2024-03-19 9:39 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director 10% Owner | 3,162,729 | $0 | 3,189,709 (Indirect) | View |
Ownership | 2024-03-08 5:43 pm | N/A N/A | AdaptHealth Corp. | AHCO | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. DEERFIELD PARTNERS L.P. Deerfield Private Design Fund IV L.P. Deerfield Mgmt L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 27,654,923 (Indirect) | View |
| 2024-02-06 Conversion | 2024-02-08 2:07 pm | N/A N/A | Fractyl Health Inc. | GUTS | Flynn James E Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Possible Members of 10% Group 10% Owner | 2,624,565 | $0 | 834,254 (Indirect) | View |
Ownership | 2024-02-01 6:55 pm | N/A N/A | Fractyl Health Inc. | GUTS | Flynn James E Deerfield Private Design Fund III L.P. Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Possible Member of 10% Group 10% Owner | 0 | $0 | 834,254 (Indirect) | View |
| 2023-11-17 Exercise | 2023-11-21 6:09 pm | N/A N/A | CareMax Inc. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 12,123 | $0 | 15,823,213 (Indirect) | View |
| 2023-07-28 Other | 2023-08-01 5:24 pm | N/A N/A | DA32 Life Science Tech Acquisition Corp. | DALS | DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. Flynn James E Director by Deputization Director 10% Owner | 1,600,000 | $0 | 2,250,000 (Indirect) | View |
| 2022-06-16 Option Award | 2023-06-20 8:10 pm | N/A 2032-06-16 | Acutus Medical Inc. | AFIB | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by deputization Director | 56,000 | $0 | 6,924,305 (Indirect) | View |
| 2023-06-15 Option Award | 2023-06-16 6:46 pm | N/A 2033-06-15 | Nuvalent Inc. | NUVL | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by deputization Director 10% Owner | 30,000 | $0 | 30,000 (Indirect) | View |
| 2023-06-08 Option Award | 2023-06-12 8:18 pm | N/A N/A | CareMax Inc. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 33,750 | $0 | 33,750 (Indirect) | View |
| 2023-05-09 Option Award | 2023-05-11 6:31 pm | N/A 2033-05-09 | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner | 8,300 | $0 | 8,300 (Indirect) | View |
| 2022-11-17 Option Award | 2022-11-21 7:31 pm | N/A N/A | CareMax Inc. | CMAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 12,123 | $0 | 12,123 (Indirect) | View |
Ownership | 2022-11-14 6:12 pm | N/A N/A | Frazier Lifesciences Acquisition Corp | FLAC | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner | 0 | $0 | 2,572,986 (Indirect) | View |
Ownership | 2022-11-10 7:48 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Flynn James E Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Private Design Fund III L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Director by deputization Director 10% Owner | 0 | $0 | 11,077,928 (Indirect) | View |
| 2022-06-30 Option Award | 2022-07-05 5:27 pm | 2022-06-30 2030-06-30 | Acutus Medical Inc. | AFIB | Flynn James E Deerfield Mgmt L.P. Deerfield Mgmt III L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Private Design Fund III L.P. Director by Deputization Director 10% Owner | 3,779,018 | $0 | 3,779,018 (Indirect) | View |
| 2022-06-16 Option Award | 2022-06-21 4:14 pm | N/A 2032-06-16 | Nuvalent Inc. | NUVL | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Director by Deputization Director 10% Owner | 40,000 | $0 | 40,000 (Indirect) | View |
| 2022-05-10 Option Award | 2022-05-11 5:42 pm | N/A 2032-05-10 | Larimar Therapeutics Inc. | LRMR | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) * Director by Deputization Director 10% Owner | 8,300 | $0 | 8,300 (Indirect) | View |
| 2022-05-10 Conversion | 2022-05-10 6:22 pm | N/A N/A | PepGen Inc. | PEPG | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. Possible Member of 10% Group 10% Owner | 815,106 | $0 | 476,813 (Indirect) | View |
Ownership | 2022-05-05 8:00 pm | N/A N/A | PepGen Inc. | PEPG | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 536,960 (Indirect) | View |
| 2021-11-12 Other | 2021-11-16 9:34 pm | N/A N/A | Oncology Institute Inc. | DFPH | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Possible Members of 10% Group 10% Owner | 5,150,390 | $0 | 7,972,273 (Indirect) | View |
| 2021-11-12 Conversion | 2021-11-16 9:34 pm | N/A N/A | Oncology Institute Inc. | DFPH | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. Possible Members of 10% Group 10% Owner | 85,153 | $0 | 7,972,273 (Indirect) | View |
| 2021-10-26 Conversion | 2021-10-28 7:15 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Possible Member of 10% Group 10% Owner | 15,129,450 | $0 | 1,143,972 (Indirect) | View |
Ownership | 2021-10-21 9:36 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 1,512,944 (Indirect) | View |